PUMA BIOTECHNOLOGY, INC. Public Float
PUMA BIOTECHNOLOGY, INC. (PBYI) had Public Float of $145.20 million as of 2025-06-30, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-30: Entity Public Float $145.20M.
- 2024-06-30: Entity Public Float $134.40M.
- 2023-06-30: Entity Public Float $141.40M.
- 2022-06-30: Entity Public Float $111.90M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $145.20M 10-K · filed 2026-02-26 |
| 2024-06-30 | $134.40M 10-K · filed 2025-02-27 |
| 2023-06-30 | $141.40M 10-K · filed 2024-02-29 |
| 2022-06-30 | $111.90M 10-K · filed 2023-03-02 |
| 2021-06-30 | $373.90M 10-K · filed 2022-03-03 |
| 2020-06-30 | $413.30M 10-K · filed 2021-03-01 |
| 2019-06-28 | $427.60M 10-K · filed 2020-02-28 |
| 2018-06-29 | $2.00B 10-K · filed 2019-03-01 |
| 2017-06-30 | $2.48B 10-K · filed 2018-03-09 |
| 2016-06-30 | $505.79M 10-K · filed 2017-03-01 |
| 2015-06-30 | $2.04B 10-K · filed 2016-02-29 |
| 2014-06-30 | $1.12B 10-K · filed 2015-03-02 |
| 2013-06-30 | $703.21M 10-K · filed 2014-03-03 |
| 2012-06-30 | $135.78M 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |